What this means
This is a trial plan that has not reported results yet. It tells us the program is planned, but not whether it helps frailty.
Plain-English summary written by an AI model from the registry listing.
- Status
- Recruiting
- Who can join
- Ages 65 and over
- Where
- 2 sites
The science
- Registered title
- Effectiveness of a Personalized 6-month Programme on Frailty in Older Patients Treated for Bladder or Kidney Cancer.
- Trial ID
- NCT07073703 ↗
- Phase
- Not applicable
- Study type
- interventional
- Conditions
- Bladder (Urothelial, Transitional Cell) Cancer, Kidney (Renal Cell) Cancer
- What is tested
- APA, Therapeutic education workshops, DAPAP
- Sponsor
- Centre Hospitalier Universitaire de Saint Etienne
- Ages
- 65 Years to no maximum
- Dates
- First posted Jul 18, 2025 · updated Dec 9, 2025
Registry summary
Bladder and kidney cancers are commonly diagnosed in older adults. Surgery remains the primary treatment modality for patients with kidney or bladder cancer. In older patients, common co-morbidities include fatigue, physical deconditioning characterized by reduced cardiorespiratory fitness and progressing sarcopenia, pain- whether disease- related or treatment-induced- and undernutrition. These factors increased the risk of post-operative complications and exacerbate patient frailty.
The investigators propose a personalized 6-month program both pre- and post-surgery, including adapted physical activity sessions, therapeutic education workshops, and systematic referral to the department's DAPAP program.
Sites (2)
- Chu Saint-Etienne, Saint-Etienne, France
- Hôpital privé de la Loire, Saint-Etienne, France